For: | Fragkou N, Sideras L, Panas P, Emmanouilides C, Sinakos E. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence? World J Gastroenterol 2021; 27(27): 4252-4275 [PMID: 34366604 DOI: 10.3748/wjg.v27.i27.4252] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i27/4252.htm |
Number | Citing Articles |
1 |
Wen‐Qiang Wang, Guang‐Yuan Xu, Jian Li, Bin‐Yong Liang, Jiang Li, Mei‐Long Lin, Xiao‐Ping Chen, Er‐Lei Zhang, Zhi‐Yong Huang. HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma. Cancer Medicine 2023; 12(8): 9627 doi: 10.1002/cam4.5740
|
2 |
Ruofan Sheng, Beixuan Zheng, Yunfei Zhang, Chun Yang, Dong Wu, Jianjun Zhou, Mengsu Zeng. Assessment of intrahepatic cholangiocarcinoma with LI-RADS in the high-risk population: MRI diagnosis and postoperative survival. Cancer Imaging 2025; 25(1) doi: 10.1186/s40644-025-00860-6
|
3 |
Se Jin Choi, Dong Hwan Kim, Sang Hyun Choi, So Yeon Kim, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin. Comparison of MRI and prognostic features of intrahepatic cholangiocarcinoma between patients with and without hepatitis B virus infection. Abdominal Radiology 2025; doi: 10.1007/s00261-025-05034-3
|
4 |
Ruofan Sheng, Heqing Wang, Yunfei Zhang, Wei Sun, Kaipu Jin, Yongming Dai, Weiguo Zhang, Mengsu Zeng, Jianjun Zhou. MRI for Hepatitis B‐Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study. Journal of Magnetic Resonance Imaging 2024; 59(3): 1093 doi: 10.1002/jmri.28855
|
5 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 291 doi: 10.1002/9781119756422.ch17
|
6 |
Tyng‐Yuan Jang, Chi‐Chang Ho, Chih‐Da Wu, Chia‐Yen Dai, Pau‐chung Chen. Air pollution as a potential a risk factor for pancreatic cancer and cholangiocarcinoma in Taiwanese patients. Advances in Digestive Medicine 2025; doi: 10.1002/aid2.13426
|
7 |
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 2022; 23(21): 13612 doi: 10.3390/ijms232113612
|
8 |
Sungeun Park, Boyeon Koo, Boryeong Jeong, Sang Hyun Choi, Jeong Min Lee. LI-RADS Category Can Be a Post-Surgical Prognostic Factor for Intrahepatic Cholangiocarcinoma in Patients with Liver Cirrhosis or Chronic Hepatitis B. Liver Cancer 2024; : 1 doi: 10.1159/000539794
|
9 |
Fang Luyao, Zhang Xiangnan, Min Qiaoyun, Zhang Hui, Meng Huanping, Xu Tianwen, Zhao Huanfen. A Lymphoepithelioma-Like Intrahepatic Cholangiocarcinoma With Massive Multinucleated Giant Cell Reaction. International Journal of Surgical Pathology 2025; 33(3): 706 doi: 10.1177/10668969241268392
|
10 |
Zhiqiang Chen, Hui Zhang, Long Zhang, Guoyong Han, Yao Zhang, Jindao Wu, Xiangcheng Li, Xiaoxin Mu, Xuehao Wang. Impact of Antiviral Treatment on Survival in HBV-Related Intrahepatic Cholangiocarcinoma Patients After Hepatectomy: A 14-Year Retrospective Follow-Up Study Based on the Propensity Score Matching Method. Therapeutics and Clinical Risk Management 2025; : 869 doi: 10.2147/TCRM.S520629
|